Arie Sitthichai Mobley

When Arie Sitthichai Mobley (BS'2000) began teaching at a small liberal arts university in a department for undergraduate neuroscience, she says there were many books on stem cells, but they were either too broadly or narrowly focused, or too advanced for an undergraduate course. The lack of an appropriate textbook motivated her to write her own aimed at undergraduate neuroscience students. Her experiences in the lab and classroom coalesced in a clear vision of what undergraduates needed to learn about stem cells and neurogenesis as well as the level of information required. The book is designed to help students appreciate the potential, and understand the limitations of stem cells, while providing a basic knowledge of stem cell physiology.

Science Direct, in a review of the book, reported that "this early graduate level reference describes [neural stem cells'] physiology and potential for medicine and provides students with fundamental stem cell information. An overview of stem cell sources in the human body and a brief mention of relevant diseases provide context for the value of this knowledge."

Mobley earned her diploma from South Sevier High School in Monroe, Utah in 1991 and, after graduating with a bachelor's from the School of Biological Sciences, continued at the University of Utah, earning a PhD in neuroscience. Her dissertation was on olfactory sensory neurons of the squid, Lolligungula brevis. (The squid were shipped to her in large bags of water from Galveston, Texas.) Following her graduate work at the U, Mobley did her post doctorate at Yale University where she first developed an interest in adult neurogenesis in disease states. From there she became an assistant professor at Western New England University (WNEU) in Springfield, Massachusetts.

Text book authored by Bio Alumna Arie S. MobleyAfter teaching for four years, she moved to Bar Harbor, Maine, where she is currently associate study director at the independent, nonprofit biomedical research The Jackson Laboratory. The Lab is dedicated to contributing to a future of better health care based on the unique genetic makeup of each individual. Mobley's work is focused on understanding and investigating age-related olfaction deterioration that often precedes neurodegenerative disease.

Her research has been published in journals such as the Journal of Neuroscience, Journal of Comparative Neurology, Trends in Neuroscience, Neurobiology, Aging and PNAS. Dr. Mobley has received several grants including the Ruth Kirstein National Research Service Award (NRSA) at the graduate level under Dr. Mary T. Lucero and at the postdoctoral level under Dr. Charles Greer. She went on to obtain an NIH Small Grant Program (R03) award that was instrumental in beginning her independent research program at WNEU.

"In my position as a Study Director I interface directly with customers to assess customer needs and ensure accurate capture of project specifications in order to develop detailed project plans," Mobley writes on The Jackson Lab's website. "I ensure that plans are successfully tracked and seamlessly executed by ensuring that staff understand and are compliant with all policies and procedures to ensure the most efficient operation, and provide customers with the highest quality scientific service.

"I am uniquely positioned to develop and execute strategic innovation and improvement initiatives, with the objectives to increase capacity, expand product offerings, improve service quality and improve customer experience. I participate in research validation data analysis and support implementation of new techniques and processes."

With her husband Michael, the Mobleys have one daughter.

 

 
by David Pace
 

Clifford Stocks

In these uncertain times when “the new normal” of our lives has yet to emerge, SBS alumnus Clifford Stocks (BS’80) opens a window to fresh air on the COVID-19 pandemic. That updraft comes from his scientific orientation and is underscored by his enduring ambition to use his training in biology and beyond to elevate the health of his fellow humans.

“At the end of the day the COVID-19 pandemic is a blip,” he reminds us. “Yes, it caused and will cause many premature deaths and a disruption of lifestyle, and in many cases irreversible economic burden. However, the biomedical complex in the world has become so sophisticated we will have treatment solutions and a vaccine in short order.” He continues on the updraft with a coda:  “And the world will go on as before, but hopefully this pandemic will help people remember that life can be fleeting and to stop and think about what is important to them. And to let those close to them know they are loved.”

It’s a take on this singular time that the world desperately needs right now, a perspective rooted in valuing not only science but the inviolable drive of people to persevere and to assemble ourselves into the collaborative army of our common humanity.

Stocks knows something about perseverance in both the clinical realm and in that of business. Raised in Wyoming before arriving in Salt Lake City, he wrestled in high school and received a scholarship to the University of Utah. “I wrestled four years under coach Marvin Hess,” he says. “This was the only way I could afford to attend college.”

His memories of the U include warm summer nights, trips to the desert—"the heavy focus on the outdoors and exploring the beauty and wonder of Utah”–epitomized by the slickrock country of Moab where Stocks was born. And his time studying biology gave him the opportunity to learn a range of topics in the biological sciences and to determine that he would “dedicate my life's work toward applying biology to help humankind.”

Not surprisingly, that dedication settled in Stocks largely because of important mentors while at the School of Biological Sciences, including Dr. Mario Capecchi, who would later be awarded the Nobel Prize, and whose biochemistry class “inspired in me a love and respect for the power of molecular biology.”

Dr. Robert Vickery, now SBS professor emeritus, was another formative figure for the budding scientist. He “taught evolution and cemented for me the importance of

Clifford & Renee Stocks

recognizing natural selection processes in many biological systems, says Stocks, “including the ability of cancer to form resistance and the power of differentiation in the immune system to combat infection, disease and neoplasms.”

But it was during his senior year as research technician in the laboratory of Seth Pincus, MD in the Department of Immunology at the U’s Medical Center that the young researcher found a home in science. Stocks stayed on there for four years following his graduation from the U in 1980.

After earning an MBA at the University of Chicago where he also did research in molecular genetics and cell biology, Stocks transitioned from the bench to the business side of biotech when he landed his dream position and stayed for 15 years at ICOS Corporation (before it was acquired in 2007 by Lilly and Company). Following other professional stops Stocks founded Seattle-based biotech company OncoResponse, and as CEO has narrowed his broad range of research interests to immuno-oncology. The company currently has several antibodies directed at modulating immunosuppression of the tumor microenvironment in pre-clinical development and is working toward increasing immunotherapy offerings and improving the lives of cancer patients.

“I have always loved rivers and mountains,” says the former wrestler and kayaker, turning to his life outside the world of the lab and of business. “During the '80s and '90s I was part of a world class whitewater kayaking team that conquered several first descents of rivers in North and South America. Today Stocks is an avid fly fisherman which keeps him near rivers in the mountains.  Along with his wife of 25 years, Renee, and their five children they remain focused on academics, athletics and the outdoors.

“Life and career are a journey so make sure to enjoy it and do not let obstacles weigh you down,” he advises. “Oh, and wear your mask to protect others from the spread of COVID-19, and expect others to do same, to protect you and your loved ones.”

The pandemic may be a “blip,” in the organic scheme of things, but it is also, potentially, a transformative opening for inquiry, discovery and resolution. It is an opportunity for all of us, especially, perhaps, for those at the forefront of public health and in the science-inflected imaginations of those like Clifford Stocks.

 
by David Pace, photo by Cassie Redstone
 

Griffin Chure

Griffin Chure’s favorite memory of his time at the U was working in Dr. David Blair’s research lab. “During the summers, when class-load was low,” he says, “we characterized the flagellar protein of FIhE, a protein of unknown function." His interactions with Blair and Dr. Sandy Parkinson “firmly set” him on a path towards a career in research.

With a base of confidence provided by mentors in the School of Biological Sciences (SBS), Chure found a natural segue into biophysics, propelled by a course he took from Dr. Saveez Saffarian in 2012. That work “solidified my deep interest in the intersection of biology and physics,” he says, the area in which, after graduation with honors in 2013, he spent his entire graduate career, culminating in 2020 with his PhD in Biochemistry and Molecular Biophysics, at the California Institute of Technology Pasadena.

Griffin Chure

Currently, Chure is a postdoctoral scholar in the Department of Applied Physics at Caltech while next year he will be moving to Stanford University as a National Science Foundation Postdoc Research Fellow to work with Prof. Jonas Cremer. There he will help develop and experimentally test physiologically-grounded mathematical models of bacterial evolution.

Chure’s journey started in the small Green River-side town of Jensen (population 412), seventeen miles from the Colorado state line in Uintah County. “Being raised in rural Utah,” he says, “the option to attend a university with a strong standing in the biological sciences and [to] remain close to family and nature made my choice to attend the U an easy one.” SBS was clearly lucky to get Chure as he continues advancing academically at some of the most prestigious research universities, which like the U, are members of the American Association of Universities, composed of the nation’s top research universities.

His advice to students is to explore science and to do it outside of their comfort level. “It is also important,” he says, “to be sure to be involved in science outside the classroom.” It wasn’t until his graduate studies, he explains, that he was “exposed to the beauty that is probability theory, linear algebra, dynamical systems, and other subfields.” That coupled with extensive training in computer programming “foundationally changed the way I pursue research in biology. The future of biology will be written in the language of mathematics, and quantitative methods should become a central feature of biology education at the U.”

Looking at the larger picture of society and science, Chure is worried that we “live in a time where objective truth and reality seems to be losing its importance with the general populace, even to the point where wearing face coverings has become viewed as a political statement.” Work hard, he says, to convey the science you’re doing to the general public. Even beyond the pandemic, he believes, the only way to fight the erosion of trust in science is to help improve the communication.

Outside of research the recently-minted PhD from Utah has a passion for graphic design and art which dovetails nicely with the work of his wife Bárbara de Araujo Soares who writes Hollywood screenplays. They feel fortunate to have gainful employment during the pandemic. “Going forward, the biggest impact this virus will (hopefully) have on our world,” Chure says, “will be a paradigm shift on how we view and support social causes such as health care, homeless and veteran services, and equitable income support.”

 

 

 
by David Pace
 

Jeffrey Webster

 

Jeffrey Webster (BS'81)

A native of Chagrin Falls, OH, Jeff Webster, MD, FAAOS, found himself as an undergraduate at the University of Utah for "not the most mature reason, but it's true": the easy access to the world class skiing. He might be surprised at how common the denominator is for arriving freshmen who are held in rapture by the opportunities for outdoor recreation in the nearby Wasatch Mountains.

Whether skiing was an adjunct to the degree he sought in biology as a pre-med student ... or the reverse, will remain obscured for now. What he did find in Salt Lake City in the late 70s was that the U was his crucible for a successful life. "The U made me realize that school and life aren't easy, that you have to do solid, honest work to forge your path."

That path culminated in his career as an orthopedic surgeon, currently at the Reno Orthopedic Clinic. After graduating from the U, he attended Wayne State University for his MD followed by a residency at Indiana University. A sports medicine fellowship at Methodist Hospital in Indianapolis then propelled him back to the west near another ski town, this time at the foot of the Sierra Nevada.

While in Utah the slopes had to compete with another passion of Webster's: his two years on the swim team between 1979 and the year he graduated in 1981. "Under coach Don Reddish I made lifelong friends, learned many life lessons, and met my wife Bridget Duncan Webster of over 36 years now." In the off-season he found himself at the bench doing research. I "did a student project," he explains, "self designed, regarding anabolic steroids in rats. Doc [James] Lords supervised. [It] was never published or presented, but was fun to do. The rats surely would have disagreed with the 'fun to do' part." Typical of the School of Biological Sciences' reputation for the informality with which world-class faculty and students collaboratively interact, Webster remembers sitting more than once in Lords' office where they would "shoot the breeze, talk biology, sports, whatever."

As for today, the clinic where Webster works has been, for over sixty years, a magnet for some of the best and brightest in orthopedic medicine. As one of 30 physicians, the Northern Nevada clinic boasts "the kind of comprehensive, world-class care typically only seen in major metropolitan areas." And, along with all medical practitioners right now, Webster, a Fellow of the American Academy of Orthopedic Surgeons, acknowledges the current challenges in the field because of the Covid-19 pandemic. "The impact has been tremendous, and not all in a good way," he says. "The daily inconveniences are certainly a nuisance, but tolerable. It’s the political malfeasance that’s concerning to me." Even so, he muses, the "virus situation has brought family and friends closer, allowing us to appreciate the most important things in life."

His advice to undergraduates currently navigating their education while wearing masks, social distancing and living with the uncertainty of what's next during this singular time is philosophical:  "Be humble, choose your goals, and work diligently in accomplishing them. The basic tenets of western civilization, Christianity for example, are extremely important and powerful. Lead a virtuous life. ...While not very religious per se, I’ve become more spiritual with time."

Dr. Webster quips that he still loves to ski, though he isn't ready to say if Tahoe is as good as "the greatest snow on earth" of Alta and Snowbird. Fortunately, for both this Ohio native and the School of Biological Sciences, they still share the same Great Basin, across the west desert and the salt flats, connected still by the legacy of the University of Utah.

 

 
by David Pace
 

Forest Futures

Forest Futures


Know the risks of investing in forests.

Given the tremendous ability of forests to absorb carbon dioxide from the atmosphere, some governments are counting on planted forests as offsets for greenhouse gas emissions—a sort of climate investment. But as with any investment, it’s important to understand the risks. If a forest goes bust, researchers say, much of that stored carbon could go up in smoke.

In a paper published in Science, University of Utah biologist William Anderegg and his colleagues say that forests can be best deployed in the fight against climate change with a proper understanding of the risks to that forest that climate change itself imposes. “As long as this is done wisely and based on the best available science, that’s fantastic,” Anderegg says. “But there hasn’t been adequate attention to the risks of climate change to forests right now.”

Meeting of Minds

William Anderegg

In 2019, Anderegg, a recipient of the Packard Fellowship for Science and Engineering from the David and Lucile Packard Foundation, convened a workshop in Salt Lake City to gather some of the foremost experts on climate change risks to forests. The diverse group represented various disciplines: law, economics, science and public policy, among others. “This was designed to bring some of the people who had thought about this the most together and to start talking and come up with a roadmap,” Anderegg says.

This paper, part of that roadmap, calls attention to the risks forests face from myriad consequences of rising global temperatures, including fire, drought, insect damage and human disturbance—a call to action, Anderegg says, to bridge the divide between the data and models produced by scientists and the actions taken by policymakers.

Accumulating Risk

Forests absorb a significant amount of the carbon dioxide that’s emitted into the atmosphere—just under a third, Anderegg says. “And this sponge for CO2 is incredibly valuable to us.”

Because of this, governments in many countries are looking to “forest-based natural climate solutions” that include preventing deforestation, managing natural forests and reforesting. Forests could be some of the more cost-effective climate mitigation strategies, with co-benefits for biodiversity, conservation and local communities.

But built into this strategy is the idea that forests are able to store carbon relatively “permanently”, or on the time scales of 50 to 100 years—or longer. Such permanence is not always a given. “There’s a very real chance that many of those forest projects could go up in flames or to bugs or drought stress or hurricanes in the coming decades,” Anderegg says.

Forests have long been vulnerable to all of those factors, and have been able to recover from them when they are episodic or come one at a time. But the risks connected with climate change, including drought and fire, increase over time. Multiple threats at once, or insufficient time for forests to recover from those threats, can kill the trees, release the carbon, and undermine the entire premise of forest-based natural climate solutions.

“Without good science to tell us what those risks are,” Anderegg says, “we’re flying blind and not making the best policy decisions.”

Mitigating Risk

In the paper, Anderegg and his colleagues encourage scientists to focus increased attention on assessing forest climate risks and share the best of their data and predictive models with policymakers so that climate strategies including forests can have the best long-term impact. For example, he says, the climate risk computer models scientists use are detailed and cutting-edge, but aren’t widely used outside the scientific community. So, policy decisions can rely on science that may be decades old.

“There are at least two key things you can do with this information,” Anderegg says. The first is to optimize investment in forests and minimize risks. “Science can guide and inform where we ought to be investing to achieve different climate aims and avoid risks.”

The second, he says, is to mitigate risks through forest management. “If we’re worried about fire as a major risk in a certain area, we can start to think about what are the management tools that make a forest more resilient to that disturbance.” More research, he says, is needed in this field, and he and his colleagues plan to work toward answering those questions.

“We view this paper as an urgent call to both policymakers and the scientific community,” Anderegg says, “to study this more, and improve in sharing tools and information across different groups.” Read the full paper @ sciencemag.org

 

 

by Paul Gabrielsen first published in @theU

 

Ole Jensen

On the surface, Ole Jensen’s start as an undergraduate biology major, angling for medical school, didn’t appear particularly auspicious. His one claim to fame was that as an undergraduate the Salt Lake native was tapped to be a “calf sitter,” which meant that he would sit all night with young bovine used in experiments and monitor their heart rates. The calves were a critical part of the University’s artificial organ program which would eventually produce the world’s first artificial heart in the 1980s.

Not bad for a Utah boy who, when he wasn’t fishing with his Norwegian-born father on the Provo River and elsewhere, spent much of his early life collecting what would become one of the largest insect collections in the state.

It was a heady time to be studying biology at the U. Department Chair Gordon Lark was bringing in guest lecturers and expanding the faculty at a prodigious rate, including micro-biologist Mario Capecchi who would eventually be awarded the Nobel Prize for his work in genetics. Jensen recalls his time in the early seventies as an undergraduate at the U. One day, he says, anatomy professor Stephen Durrant “threw out twenty animal bones spread over a long table and asked the students to identify […them] as part of the midterm exam.” It turned out that the students, who in class had been studying strictly land mammals, got very few correct answers. “One bone that very much perplexed me that I remember to this day,” Jensen continues, “was half of a frontal bone with an ovoid depression. It was from a dolphin: the depression access for the spout!” Needless to say, it was “a particular shock” to find a marine mammal bone in the pile, but it was an experience that Jensen still recalls with some exhilaration.

After graduating from dental school at Northwest University, Jensen continued to Michigan to study oral surgery and, as a post doc, anesthesia, which would eventually lead to a Master’s degree in anesthesiology before returning to the west where he set up practice in Denver. There he plied his trade, as both a science and an art, for the next 38 years. But research has continued to braid its way through his entire professional life—a continuous thread that has kept him at the forefront of the fast-moving field of oral and maxillofacial surgery in which technology, the life sciences and medicine converge. As with many oral surgeons, Jensen performed four-on-one implant operations, which combine bridgework with a maximum of four implants per each of the crescent arrangements or arches.

Eventually, he modified the procedure so that it was less invasive and more intuitive, underscored by his determination to see the implant not as an analogue to a tooth (or teeth) but as a function of bio-mechanical forces, mathematically determined. Eventually he would join forces with business partners to found Clear Choice Dental Implants. “Basically, for five years I wanted to die,” Jensen says of the start-up which now has forty clinics across the nation. The company nearly failed three times, including during the recession of 2008. “I wanted to practice . . . business with integrity, and to be doing things in the best interests of the patients. It’s hard to do that with this kind of work where it’s not too costly and not too difficult for doctors to perform.” In a recent DentalTown podcast, Jensen explains, “If you have a business that is related to dental implants, you’re not going to do stuff that will put the business at risk."

"So this has a business, scientific, and a clinical basis of validity," he says ". . . [and] we stand by the way we treat our edentulous patients… .” Of course success is never final. With his rigorous research background and his bias for asking lots of questions, this time about biofilm, the pervasive glue-like matrix that grows virtually everywhere and can lead to complications in bio-medical work, Jensen took on yet another professional challenge. In September he was hired as Chief Medical Officer for Israel-based NOBIO, helping to create products through Nano-technology in which particles with superior micro-biotic activities are baked into the product to prevent bacteria from growing on surgically implanted devices.

Jensen’s research questions, especially as they’ve related to medicine, have been open ones. “Almost everything I’ve done is in surgery,” he says. “Now I’m doing a project with computers,” referring to his latest adventure. Inspired by the training of pilots who learn to fly by logging many hours in flight simulators, Jensen and his team at Massachusetts General Hospital in Boston are developing a program for surgical simulations.

The Gandhis

Last December, when the three Gandhi children, Rajesh BS’86, Monica BS’91 and Leena BS’92 returned home to Salt Lake City—two from one coast, and one from the other—they celebrated their parents fifty-fifth wedding anniversary. As alumni, all three, from the School of Biological Sciences, they must have had a lot to reflect on.

Their father, Om, now aged 84, had brought his young family to the U in 1967 during the “summer of love” from their native India when Rajesh “Tim,” the only child at the time, was three years old. A Professor of Electrical Engineering at the U for over 50 years (and former department chair) Om has since retired. Says Rajesh, “We essentially grew up in the Merrill Engineering Building.” He and his sisters remember department picnics and other college events. “We were especially impressed as children with all of the colored chalk they had in the classrooms,” remembers Rajesh. Both Om and the Gandhi children’s mother (Santosh) had to leave home at a young age to pursue further education. After Om earned his PhD at the University of Michigan in the late 50s, he returned to the subcontinent where he taught physics for a time in a small town in India before accepting an opportunity to return to the U.S. He chose the U.

Once the children were older, Mrs. Gandhi returned to school herself, and even took classes from her husband. Far from showing her favoritism, he insisted on only answering her questions during office hours! She eventually finished her degree in computer programming before taking a position at the Salt Lake branch of 3M.

It was an educated family, for sure, and all in the sciences. It was also a family inextricably tied to the University of Utah. All three of the Gandhi children attended the U because it was local, “a function of my parents’ having to leave home early [in their studies] in post-partition India,” says Monica who attended Harvard for her MD and who is currently Professor of Medicine and Associate Chief of the Division of HIV, Infectious Disease, and Global Medicine at UCSF. She also serves as Medical Director of the Ward 86 HIV Clinic at San Francisco General Hospital, one of the oldest HIV clinics in the country. All three siblings remember the excitement of coming to the U after going to public schools in the 1970s/80s, recalling how it broadened their horizons from the more limited experiences they had growing up.

“We were all pretty much wedded to the U. Part of our ethos growing up” in Utah, continues Monica. Attending the U was liberating, they say, mind-opening with a bit of counter-culture at play after going through the public school system in Salt Lake. And certainly it was formative.

“I was moved to enter HIV care,” says Monica, “after growing up in a place where I saw friends coming out as gay in high school struggle with stigma. I also became interested in infectious diseases, which differentially affect the poor, after going to India several times as a child to visit grandparents and witnessing the stark contrast between rich and poor. This set me on the path to medical school.

” Beginning her sophomore year Monica worked on chemotaxis in E.coli with her undergraduate advisor Dr. John (“Sandy”) Parkinson in his lab. She will be returning to Utah as this year’s convocation speaker in May. She describes the Bay Area where she currently lives as a place “that couldn’t be more different than Utah.” Although San Francisco is generally a place where gay and transgender individuals have sought refuge from more conservative places throughout the U.S., “stigma towards people living with HIV still exists and must constantly be combatted,” she says.

Before Monica enrolled in the U, Rajesh, five years older, worked in Dr. Baldomero “Toto” Olivera’s lab, the celebrated faculty researcher whose subject model is poisonous cone snails. “Toto was an incredible mentor to me and to countless others,” says Rajesh. “He taught me the transformative power of science and set me on the road to a career in biology and medicine. I would not be where I am without his encouragement and influence.”

Rajesh’s U experience was as much about philosophy and history as biology. Both he and Leena remember fondly the five-term Intellectual Traditions of the West colloquia with professors like the beloved theologian and classicist Dr. Sterling McMurrin. “At the U, I experienced a whole new world from my time in public schools,” says Rajesh. “It was a place packed with people of diverse experiences, interests and perspectives. It was a vibrant and exciting place to be.”

Around the time Rajesh entered medical school, also at Harvard, he recalls with Monica, the state of affairs of that singular time in American medical history. “HIV was just ramping up. It was a devastating disease and one that was being defined in front of our eyes.” Between 1988–90, the medical sector was furiously attempting to figure out how the disease manifested itself. Treatments were very poor. He especially admires Kristen Ries, MD, MCAP who for a time was head of the clinic at the U serving HIV/AIDS patients. The difference, he says, between the attitude toward the sick in small towns compared to, again, a place like San Francisco at this time was “very moving to me,” he says. Currently, he practices medicine in Boston where he is a specialist in infectious disease and Medical Director of the HIV Clinic at Massachusetts General Hospital and Professor of Medicine at Harvard Medical School. He is also actively involved in HIV clinical research, working on discovering a cure for HIV—the disease that defined his generation.

While all three Gandhis ended up as medical doctors, Leena, who has focused on oncology for the past 10-plus years, currently leads early drug development at Lilly Pharma. Leena earned her PhD at the University of California Berkeley in DNA replication studies before attending New York University for medical school, followed by her residency at Mass General and a fellowship at Harvard Medical School, both in Boston. She characterizes her experience at the U as providing “a genuine ‘college experience’. [The School of Biological Sciences] …was all about scientific inquiry,” she says. “I learned something every day from [then] junior faculty like Dr. Mary Bekerhle [now head of the Huntsman Cancer Institute].” Leena also worked in Ted and Tucker Gurney’s lab in cell biology.

“The spirit of scientific inquiry was everywhere,” she continues, “and it really motivated me to go on for a PhD in the science of medicine and the early development of drugs… At the U, I learned that science drives how we interact at the macro level. It was very grounding.” With the benefits of the novel field of immune-oncology, Leena still has patients who have been free of cancer for more than ten years. But, of course, there is still work to be done. “At Lilly I’m able to do work at a much larger scale and with a much broader population.”

The Gandhi Effect found in Rajesh, Monica and Leena Gandhi— from “sea to shining sea”—is indeed a rarity, what one might call “A Triple Threat” that the School is proud to embrace.

Our DNA Magazine

Dominique Pablito

Dominique Pablito

"My interest in medicine stems from my childhood experience."

Dominque Pablito grew up in the small town of Aneth, Utah, on the Navajo Nation, and in New Mexico on the Zuni Reservation. She lived in a four-bedroom house with 13 family members, sharing a bedroom with her mother and brother, and visited relatives for extended stays.

“I spent time with my great grandmother, whose house had no running water or electricity,” said Pablito.

Because her grandparents did not speak English, Pablito learned the Zuni and Navajo languages. Pablito said her father, an alcoholic, came in and out of her life.

“I spent time with his family in the Zuni Pueblo,” said Pablito. “I love the connection that the Zuni have with the land and the spirits of the land.”

With access to math and science courses limited in reservation schools, Pablito convinced her family to move.

“We ran out of gas in Saint George, Utah, where I registered for high school even though my family was unable to find housing,” said Pablito. “During my first quarter at my new school, I slept in a 2008 Nissan Xterra with my mother, brother and grandmother while I earned straight As, took college courses at Dixie State University and competed in varsity cross country.”

Pablito met her goal of graduating from high school in three years, racking up honors and college credits.

“My mother told me I would have to excel in school to get a scholarship for college,” said Pablito. “When I graduated at 15 with an excellent GPA, having taken college courses at night and with exceptional ACT and SAT scores, I was sure I would earn the Gates Millennium Scholarship. It wasn’t enough.”

Dominique Pablito

To compensate, she applied for 15 scholarships and was awarded 12, including the Larry H. Miller Enrichment Scholarship—a full ride.

For Pablito, the transition to college life was jarring.

“It was the first time I had my own bed in my own bedroom,” said Pablito. “I missed being so close to my Zuni culture. I brought small kachina figurines with me and did my best to decorate my room like my old homes.”

Despite her hard work in high school, Pablito was not prepared for college academics and sought help from tutors, professors, and TAs.

“I spent late nights watching tutorials on YouTube,” said Pablito. “College retention rates for indigenous students are exceptionally low, so instead of going home for the summer, I sought out research internships and difficult coursework to keep busy.”

Academics were not her only challenge.

“I started college at 15 and by age 16 I had no parents,” said Pablito. “My mother was abusive and we ceased contact. At 17, I was diagnosed with an adrenal tumor, which pushed my strength to its limits. I never felt more alone in my life.”

For support, she turned to her grandparents.

“Hearing their voices speaking the languages I grew up with helped with my loneliness,” said Pablito. “My grandfather didn’t allow me to drop out of college.”

Pablito also reached out to Indigenous student groups.

“I joined AISES and the Hospital Elder Life Program (HELP), which connected me with community elders,” said Pablito. “I tutored students in math and science and assisted in teaching Diné Bizaad (Navajo) to students who had never heard the language. Being a part of these communities has been crucial in my success.”

She also credits her research internships with helping her discover her strengths.

“I decided to major in chemistry when I participated in the PathMaker Research Program at the Huntsman Cancer Institute, where I used biochemistry to investigate DNA damage and repair in cancer cells,” said Pablito. “Dr. Srividya Bhaskara guided me through the world of research, helping me earn many awards and grants.”

In the lab Pablito learned the important lesson that failure is inevitable.

“I began to think that science wasn’t for me, until I understood that failure is a part of research,” said Pablito. “What matters is how you handle that failure.”

She had a different lab experience during an internship at Harvard Medical School and Massachusetts General Hospital. There she used targeted photoactivatable multi-inhibitor liposomes to induce site-specific cell damage in various cancer cells.

“That’s where my research interest in cancer and molecular biology developed,” said Pablito. “That internship taught me how to effectively present scientific data and how important community can be for the success of Native students.”

Her interest in medicine stems from her childhood experience with the Indian Health Service.

“Many of my elders distrusted going to doctors because most health care providers are white,” said Pablito. “My great-grandfathers’ illnesses could have been treated much better had they visited a doctor sooner. I will use my medical training to improve the care of elders on my reservation by integrating culture, language and medicine.”

In addition to earning an MD in family medicine, Pablito plans to earn a doctoral degree in cancer biology and eventually open a lab on the Zuni Pueblo to expose students to research.

“I want to spark an interest in STEM in future generations of Indigenous scholars,” said Pablito. “I want to give them advantages I never had.”

 

by D.J. Pollard
American Indian Science and Engineering Society (AISES).

The AISES magazine, People in Winds of Change, focuses on career and educational advancement for Native people in STEM fields. The article below first appeared in the Spring 2020 Issue.

 

 

2020 Churchill Scholar

Michael Xiao

Five for Five.

Michael Xiao brings home the U's fifth straight Churchill Scholarship.

Five years after the University of Utah became eligible to compete for the prestigious Churchill Scholarship out of the United Kingdom, the university has sported just as many winners. All of them hail from the College of Science, and all were facilitated through the Honors College which actively moves candidates through a process of university endorsement before applications are sent abroad. The effort has obviously paid off.

“These students are truly amazing,” says Ginger Smoak, Associate Professor Lecturer in the Honors College and the Distinguished Scholarships Advisor. “They are not merely intelligent, but they are also creative thinkers and problem solvers who are first-rate collaborators, researchers, learners, and teachers.”

The most recent U of U winner of the Churchill Scholars program is Michael Xiao of the School of Biological Sciences (SBS).

While early on he aspired to be a doctor, Xiao’s fascination with how mutations in the structure of DNA can lead to diseases such as cancer led him to believe that while it would be one thing “to be able to treat someone, to help others, it would be quite another to be able to understand and study the underpinnings of what you’re doing and to be at its forefront.” This is particularly true, right now, he says, with the advent of the coronavirus.

Michael Xiao

The underpinnings of Xiao’s recent success started as early as eighth grade in the basement of his parent’s house where he was independently studying the effects of UV light damage on DNA. To quantify those effects he was invited to join a lab at nearby BYU where faculty member Kim O’Neill, Professor of Microbiology & Molecular Biology mentored him through high school, even shepherding him through a first-author paper.

Since then Xiao has matured into a formidable researcher, beginning his freshman year in the lab of Michael Deininger, Professor of Internal Medicine and the Huntsman Cancer Institute, followed by his move to the lab of Jared Rutter, a Howard Hughes Medical Institute Investigator in biochemistry. With Rutter he studied the biochemistry of PASK and its roles in muscle stem cell quiescence and activation of the differentiation program. His findings provided insight into the role and regulation of PASK during differentiation, as well as a rationale for designing a small molecule inhibitor to treat diseases such as muscular dystrophy by rejuvenating the muscle stem cell population.

Early experience in a research lab is not only about engaging the scientific method through new discoveries but also about making academic connections that lead to auspicious careers.

Sir Winston Churchill

One of those connections for Xiao was with Chintan Kikani now at the University of Kentucky. In fact the two of them are currently finishing up the final numbers of their joint PASK- related research.

The Churchill award, named after Sir. Winston Churchill, will take Xiao to Cambridge University beginning in October. While there, Xiao plans to join the lab of Christian Frezza at the MRC Cancer Unit for a master’s in medical science. After returning from the UK, Xiao plans to pursue an MD/PhD via combined medical school and graduate school training in an NIH-funded Medical Scientist Training Program.

Xiao is quick to thank his many mentors as well as SBS and the Honors College, the latter of which, he says, taught him to think critically and communicate well, especially through writing. Honors “was very helpful in helping me improve in a lot of areas,” he says, “that are important to my work and my personal life as well.”

Denise Dearing, Director of the School of Biological Sciences at the University of Utah describes Michael Xiao as one who “epitomizes how early research opportunities are transformative and how they ‘turbo-charge’ the likelihood of creating world-class scientists. The School is first in line to congratulate him on receiving this extraordinary award.”

 

by David Pace

 

- First Published in OurDNA Magazine, Spring 2020

Related Posts

 

Karl Gordon Lark

photo by Ben Okun

Karl Gordon Lark, Distinguished Professor Emeritus at the University of Utah, passed away on April 10, 2020, after a seven-year battle with cancer. A renowned geneticist, Lark uncovered fundamental aspects of DNA replication and genetics across many systems, from bacteria to soybeans to dogs. He came to the U in 1970 as the biology department’s inaugural chair with a vision—to build a research and teaching powerhouse in the desert. In just six years he recruited 17 faculty members from all biological disciplines, establishing an institution of scientific excellence.

“Today, the tremendous impact of Gordon’s vision and leadership are felt in the School of Biological Sciences, across campus and throughout the state of Utah,” said Denise Dearing, director of the school. “Gordon was responsible for the expansion of molecular biology—a new field in those days—across the U. He will be dearly missed.”

“The [University of Utah’s] nascent research community, in every field from molecular biology to community ecology, was built by Lark in creative, often wildly unconventional small steps,” wrote Baldomero “Toto” Olivera, Distinguished Professor of Biological Sciences, in an unpublished essay for the Annual Reviews of Pharmacology and Toxicology.Olivera conducts world-renowned research on cone snail venom and pain management, and was recruited by Lark. “It is his guidance that makes me feel unconstrained in exploring unusual solutions to seemingly intractable problems.”

Lark was preceded in death by his first wife, Cynthia (née Thompson). He is survived by his four children, Clovis, Ellen, Suzanna and Caroline and his granddaughter, Willow. He is also survived by his second wife, Antje Curry, his stepdaughter, Tara, and her two children, Liam and Briar. 

A life of inquiry

Curiosity and coincidence guided Lark’s lifelong pursuit of discovery. He was born on Dec. 13, 1930, in West Lafayette, Indiana, into a household that valued intellect. His father was physics chair at Purdue University and his mother was an artist and psychiatrist. Lark was precocious in his academic pursuits and enrolled at the University of Chicago a year after World War II ended at the age of 15. There, he met Leo Szilard, regarded as the father of the Manhattan Project but who had turned his attention from nuclear reactions to the newly emerging field of the molecular basis of life. Szilard suggested that Lark spend the summer at Cold Spring Harbor, a famous laboratory that helped develop the field of molecular biology. There, Lark met Mark Adams, a scientist from New York University who would become Lark’s mentor.

Adams studied phages, which are viruses that invade bacterial cells and take over various host functions to propagate themselves. He not only inspired Lark’s love of research, but also taught him how to organize effective undergraduate science education. In the fall, Lark returned to Chicago to complete his degree and had his first eureka moment—he discovered reversible changes in the physical structure of phage proteins. It would be about four more years before the field generally accepted that molecules could change a protein’s shape.

“To this day, I think it’s one of the best pieces of science I’ve ever done,” Lark reflected in comments to the U’s American West Center. “It was the bringing together of physics and chemistry and biology into one moment. I didn’t think of it that way at the time, but from then on I was hooked!”

Lark returned to Cold Spring Harbor in the summer of 1950 to work with Adams, and there he met his future wife and scientific collaborator, Cynthia. Lark completed his doctorate at NYU, spent two years as a postdoc at the Statens Serum Institut in Copenhagen, Denmark, and one year at the University of Geneva. On subsequent return visits, he met Costa Georgopoulos, a biochemist who discovered a new class of proteins called chaperones. More than 20 years after they first met, Georgopoulos would move to the Department of Biochemistry at the U.

“Gordon and I shared many old friends and colorful memories from our times in Switzerland,” Georgopoulos remembered. “Gordon’s nickname in the lab was ‘double-decker’ because his plentiful, high-rising hair resembled a double-decker bus.”

In 1956, Lark accepted a position at St. Louis University Medical School. Here, Lark had what he called his second epiphany—an experiment to show that in the absence of protein synthesis, replication of DNA stopped at a particular point on the bacterial chromosome. The experiment set the course of his research for the next two decades. In 1963, the Larks moved on to the physics department at Kansas State University where they focused their research on the process of DNA replication in bacteria. They pioneered how to measure the point when DNA begins replicating, how to track the progression of replication in living cells and developed the technique of measuring the size of cells before they begin to replicate. In 1965, the American Association for Microbiology honored Lark with the Ely Lilly Award, given each year to recognize landmark research in microbial physiology.

Building scientific and teaching excellence in Utah

In 1970, the U’s Robert Vickery recruited Lark to build a powerful new biology department in what would become the School of Biological Sciences in 2014. And build he did. During his time as chair from 1970-77, he hired 17 new tenure-track faculty, including Mario Capecchi who would subsequently become a Nobel Prize laureate, Raymond Gesteland and Ray White, who went on to establish new departments in the School of Medicine.

“As chair, Gordon was an unusually skilled administrator, combining a rare insight into the environment that different members of faculty and staff needed to succeed and the energy to provide it,” said Capecchi. “I was attracted to the young Utah biology department in part by Gordon’s support of long-term studies aimed at significant problems, but without the promise of immediately publishable results, quite different from the ‘publish-or-perish’ policies imposed at many other places.”

Lark also impressed the importance of teaching to the biology faculty, both by personal example and with innovative programs. In the department’s very early days, he hired one of the world’s most charismatic young science personalities, David Suzuki, as a visiting scholar to teach the introductory course in genetics. He implemented video recordings of well-taught introductory courses so they could be offered more frequently to more students. For several years as chair, he funded an annual program in which a prominent faculty member from outside the College of Science taught a course in their own area, designed for biology students.

“During Gordon’s final years after retirement and while battling cancer, he voluntarily and unpaid taught an Honors course for a general student audience. With biographical and autobiographical readings, he introduced the human sides of pioneers in the exciting advances of 20th century physics and chemistry, several of whom Gordon had known personally,” said Larry Okun, professor emeritus of biology. “He taught that course right through 2019, his own last fall semester.”

In Utah, the Larks turned their attention from bacteria to plant cells and tissues, particularly soybeans, for the next decade. In the early 1990s, disaster and serendipity struck—the Lark lab was destroyed while the building was under renovation. After a year of trying to salvage their work, they switched to studying whole soybean plants in agricultural fields, focusing on the genetics underlying certain traits, such as the ability of the crop to adapt to different climates. Overall, their laboratory identified genes that increased the yield of soybeans by 10%.

In 1996, tragedy and serendipity struck again. The Lark’s Portuguese water dog, Georgie, had died of an autoimmune anemia disease. Heartbroken, the Larks connected to a dog breeder, Karen Miller, to buy another puppy. When the time came, Miller gave Lark the $1,500 dog for free hoping to guilt him into studying the breed’s genetics.

It worked. Miller coordinated with Portuguese water dog owners from around the country to send Lark blood samples and X-rays of their pets. What became known as “The Georgie Project,” eventually identified genes that determine the size and shape of the head, thickness of the thigh bone, shape of the pelvis and characteristics of the lower foreleg.

A legacy that spans generations

Lark formally retired from the U as a Distinguished Professor in 1999, but his legacy in biology reaches beyond his direct collaborators. The next generation of biologists also feels his influence.

“The magnitude of Gordon’s accomplishments is hard to really capture in today’s world,” said David Grunwald, professor of human genetics at the U’s School of Medicine. “Individuals can have a big effect on an institution. They can either set a precedent that honors creativity, respect and excellence, or they can make everyone feel like a cog in a machine. Gordon built a place that engendered creativity.”

The K. Gordon Lark Fund was established in 2018 by the School of Biological Sciences in anticipation of growing it to a fully endowed-chair in his name. To honor his memory, donors can make gifts to the endowment here.

 

 - by Lisa Potter